Last update 01 Nov 2024
Advenchen Laboratories Nanjing Ltd.
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Digestive System Disorders
Other Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
AL8326片治疗至少接受二线治疗方案后疾病进展或复发的小细胞肺癌患者的III期临床研
究
[Translation] Phase III clinical study of AL8326 tablets in the treatment of patients with small cell lung cancer who have had disease progression or recurrence after at least two lines of treatment
Phase III Clinical Study of AL8326 Tablets in Patients With Advanced or Recurrent Small Cell Lung Cancer After at Least Prior Second-line Treatment
评估AL2846胶囊在既往TKI治疗失败的碘难治分化型甲状腺癌中有效性和安全性的Ib期临床试验
[Translation] A phase Ib clinical trial to evaluate the efficacy and safety of AL2846 capsules in iodine-refractory differentiated thyroid cancer that has failed previous TKI treatment
100 Clinical Results associated with Advenchen Laboratories Nanjing Ltd.
Login to view more data
Login to view more data
100 Deals associated with Advenchen Laboratories Nanjing Ltd.
Login to view more data
100 Translational Medicine associated with Advenchen Laboratories Nanjing Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 1 Clinical
Phase 2 Clinical
1
3
Phase 3 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free